Sanjive Qazi - Publications

Affiliations: 
Biology Gustavus Adolphus College, Saint Peter, MN, United States 

81 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Uckun FM, Myers DE, Cheng J, Qazi S. Liposomal Nanoparticles of a Spleen Tyrosine Kinase P-Site Inhibitor Amplify the Potency of Low Dose Total Body Irradiation Against Aggressive B-Precursor Leukemia and Yield Superior Survival Outcomes in Mice. Ebiomedicine. 2: 554-62. PMID 26285772 DOI: 10.1016/j.ebiom.2015.04.005  1
2015 Uckun FM, Myers DE, Ma H, Rose R, Qazi S. Low Dose Total Body Irradiation Combined With Recombinant CD19-Ligand × Soluble TRAIL Fusion Protein is Highly Effective Against Radiation-Resistant B-Precursor Acute Lymphoblastic Leukemia in Mice. Ebiomedicine. 2: 306-316. PMID 26097891 DOI: 10.1016/j.ebiom.2015.02.008  1
2015 Uckun FM, Qazi S, Cheng J. Targeting leukemic stem cells with multifunctional bioactive polypeptide nanoparticles. Future Oncology (London, England). 11: 1149-52. PMID 25832872 DOI: 10.2217/fon.15.31  1
2015 Uckun FM, Ma H, Cheng J, Myers DE, Qazi S. CD22ΔE12 as a molecular target for RNAi therapy. British Journal of Haematology. 169: 401-14. PMID 25659406 DOI: 10.1111/bjh.13306  1
2015 Uckun FM, Myers DE, Qazi S, Ozer Z, Rose R, D'Cruz OJ, Ma H. Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia. The Journal of Clinical Investigation. 125: 1006-18. PMID 25621496 DOI: 10.1172/JCI76610  1
2015 Uckun FM, Qazi S, Ma H, Reaman GH, Mitchell LG. CD22ΔE12 as a molecular target for corrective repair using RNA trans-splicing: anti-leukemic activity of a rationally designed RNA trans-splicing molecule. Integrative Biology : Quantitative Biosciences From Nano to Macro. 7: 237-49. PMID 25567759 DOI: 10.1039/c4ib00221k  1
2015 Uckun FM, Mitchell LG, Qazi S, Liu Y, Zheng N, Myers DE, Song Z, Ma H, Cheng J. Development of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL Ebiomedicine. DOI: 10.1016/j.ebiom.2015.04.016  1
2014 Uckun FM, Qazi S, Ma H, Yin L, Cheng J. A rationally designed nanoparticle for RNA interference therapy in B-lineage lymphoid malignancies. Ebiomedicine. 1: 141-155. PMID 25599086 DOI: 10.1016/j.ebiom.2014.10.013  1
2014 Uckun FM, Ma H, Ozer Z, Goodman P, Zhang J, Qazi S. A PREVIOUSLY UNKNOWN UNIQUE CHALLENGE FOR INHIBITORS OF SYK ATP-BINDING SITE: ROLE OF SYK AS A CELL CYCLE CHECKPOINT REGULATOR. Ebiomedicine. 1: 16-28. PMID 25506060 DOI: 10.1016/j.ebiom.2014.10.019  1
2014 Myers DE, Yiv S, Qazi S, Ma H, Cely I, Shahidzadeh A, Arellano M, Finestone E, Gaynon PS, Termuhlen A, Cheng J, Uckun FM. CD19-antigen specific nanoscale liposomal formulation of a SYK P-site inhibitor causes apoptotic destruction of human B-precursor leukemia cells. Integrative Biology : Quantitative Biosciences From Nano to Macro. 6: 766-80. PMID 24910947 DOI: 10.1039/c4ib00095a  1
2014 Chatrchyan S, Khachatryan V, Sirunyan AM, Tumasyan A, Adam W, Bergauer T, Dragicevic M, Erö J, Fabjan C, Friedl M, Frühwirth R, Ghete VM, Hartl C, Hörmann N, Hrubec J, ... ... Qazi S, et al. Measurements of tt spin correlations and top-quark polarization using dilepton final states in pp collisions at sqrt[s]=7  TeV. Physical Review Letters. 112: 182001. PMID 24856688 DOI: 10.1103/PhysRevLett.112.182001  0.76
2013 Qazi S, Uckun FM. Incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia. Haematologica. 98: e151-2. PMID 24323986 DOI: 10.3324/haematol.2013.091140  1
2013 Uckun FM, Ma H, Ishkhanian R, Arellano M, Shahidzadeh A, Termuhlen A, Gaynon PS, Qazi S. Constitutive function of the Ikaros transcription factor in primary leukemia cells from pediatric newly diagnosed high-risk and relapsed B-precursor ALL patients. Plos One. 8: e80732. PMID 24278314 DOI: 10.1371/journal.pone.0080732  1
2013 Ma H, Qazi S, Ozer Z, Zhang J, Ishkhanian R, Uckun FM. Regulatory phosphorylation of Ikaros by Bruton's tyrosine kinase. Plos One. 8: e71302. PMID 23977012 DOI: 10.1371/journal.pone.0071302  1
2013 Uckun FM, Qazi S, Cely I, Sahin K, Shahidzadeh A, Ozercan I, Yin Q, Gaynon P, Termuhlen A, Cheng J, Yiv S. Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor leukemia. Blood. 121: 4348-54. PMID 23568490 DOI: 10.1182/blood-2012-11-470633  1
2013 Uckun FM, Qazi S, Dibirdik I, Myers DE. Rational design of an immunoconjugate for selective knock-down of leukemia-specific E2A-PBX1 fusion gene expression in human Pre-B leukemia. Integrative Biology : Quantitative Biosciences From Nano to Macro. 5: 122-32. PMID 22990208 DOI: 10.1039/c2ib20114c  1
2012 Uckun FM, Ma H, Zhang J, Ozer Z, Dovat S, Mao C, Ishkhanian R, Goodman P, Qazi S. Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros. Proceedings of the National Academy of Sciences of the United States of America. 109: 18072-7. PMID 23071339 DOI: 10.1073/pnas.1209828109  1
2012 Uckun FM, Cahn P, Qazi S, D'Cruz O. Stampidine as a promising antiretroviral drug candidate for pre-exposure prophylaxis against sexually transmitted HIV/AIDS. Expert Opinion On Investigational Drugs. 21: 489-500. PMID 22360744 DOI: 10.1517/13543784.2012.664635  1
2012 D'Cruz OJ, Qazi S, Yiv S, Uckun FM. A novel vaginal microbicide containing the rationally designed anti-HIV compound HI-443 (N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea]). Expert Opinion On Investigational Drugs. 21: 265-79. PMID 22292483 DOI: 10.1517/13543784.2012.655422  1
2012 Ma H, Qazi S, Ozer Z, Gaynon P, Reaman GH, Uckun FM. CD22 Exon 12 deletion is a characteristic genetic defect of therapy-refractory clones in paediatric acute lymphoblastic leukaemia. British Journal of Haematology. 156: 89-98. PMID 22017452 DOI: 10.1111/j.1365-2141.2011.08901.x  1
2012 Qazi S, Uckun FM. Stampidine as a potent epigenetic silencer of host HIV dependency factor genes in HIV-infected cells Journal of Aids and Clinical Research. 3. DOI: 10.4172/2155-6113.1000147  1
2012 Cahn P, Rolon MJ, Gun AM, Ferrari I, Dibirdik I, Qazi S, D'Cruz O, Sahin K, Uckun F. Preclinical and first-in-human phase I clinical evaluation of Stampidine, a potent anti-HIV Pharmaceutical drug candidate Journal of Aids and Clinical Research. 3. DOI: 10.4172/2155-6113.1000138  1
2011 Uckun F, Dibirdik I, Sarkissian A, Qazi S. In vitro and in vivo chemosensitizing activity of LFM-A13, a dual-function inhibitor of Bruton's tyrosine kinase and polo-like kinases, against human leukemic B-cell precursors. Arzneimittel-Forschung. 61: 252-9. PMID 21650085 DOI: 10.1055/s-0031-1296196  1
2011 Uckun FM, Qazi S, Ozer Z, Garner AL, Pitt J, Ma H, Janda KD. Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network. British Journal of Haematology. 153: 741-52. PMID 21517817 DOI: 10.1111/j.1365-2141.2011.08671.x  1
2011 Uckun FM, Sun L, Qazi S, Ma H, Ozer Z. Recombinant human CD19-ligand protein as a potent anti-leukaemic agent. British Journal of Haematology. 153: 15-23. PMID 21323891 DOI: 10.1111/j.1365-2141.2011.08583.x  1
2011 Uckun FM, Pitt J, Qazi S. JAK3 pathway is constitutively active in B-lineage acute lymphoblastic leukemia. Expert Review of Anticancer Therapy. 11: 37-48. PMID 21070101 DOI: 10.1586/era.10.203  1
2010 Uckun FM, Goodman P, Ma H, Dibirdik I, Qazi S. CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia. Proceedings of the National Academy of Sciences of the United States of America. 107: 16852-7. PMID 20841423 DOI: 10.1073/pnas.1007896107  1
2010 Uckun FM, Qazi S. Spleen tyrosine kinase as a molecular target for treatment of leukemias and lymphomas. Expert Review of Anticancer Therapy. 10: 1407-18. PMID 20836676 DOI: 10.1586/era.10.112  1
2010 Uckun FM, Qazi S. Bruton's tyrosine kinase as a molecular target in treatment of leukemias and lymphomas as well as inflammatory disorders and autoimmunity. Expert Opinion On Therapeutic Patents. 20: 1457-70. PMID 20831363 DOI: 10.1517/13543776.2010.517750  1
2010 Uckun FM, Dibirdik I, Qazi S. Augmentation of the antileukemia potency of total-body irradiation (TBI) by a novel P-site inhibitor of spleen tyrosine kinase (SYK). Radiation Research. 174: 526-31. PMID 20731589 DOI: 10.1667/RR2246.1  1
2010 Uckun FM, Dibirdik I, Qazi S. Prevention of UVB-induced skin inflammation, genotoxicity, and photocarcinogenesis in mice by WHI-P131, a dual-function inhibitor of Janus kinase 3 and EGF receptor kinase. Arzneimittel-Forschung. 60: 218-25. PMID 20486473 DOI: 10.1055/s-0031-1296276  1
2010 Uckun FM, Dibirdik I, Qazi S, Yiv S. Therapeutic nanoparticle constructs of a JAK3 tyrosine kinase inhibitor against human B-lineage ALL cells. Arzneimittel-Forschung. 60: 210-7. PMID 20486472 DOI: 10.1055/s-0031-1296275  1
2010 Qazi S, Uckun FM. Gene expression profiles of infant acute lymphoblastic leukaemia and its prognostically distinct subsets. British Journal of Haematology. 149: 865-73. PMID 20377589 DOI: 10.1111/j.1365-2141.2010.08177.x  1
2010 Uckun FM, Ek RO, Jan ST, Chen CL, Qazi S. Targeting SYK kinase-dependent anti-apoptotic resistance pathway in B-lineage acute lymphoblastic leukaemia (ALL) cells with a potent SYK inhibitory pentapeptide mimic. British Journal of Haematology. 149: 508-17. PMID 20151979 DOI: 10.1111/j.1365-2141.2010.08106.x  1
2010 Uckun FM, Qazi S, Ma H, Tuel-Ahlgren L, Ozer Z. STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress. Proceedings of the National Academy of Sciences of the United States of America. 107: 2902-7. PMID 20133729 DOI: 10.1073/pnas.0909086107  1
2010 Uckun FM, Ozer Z, Qazi S, Tuel-Ahlgren L, Mao C. Polo-like-kinase 1 (PLK1) as a molecular target to overcome SYK-mediated resistance of B-lineage acute lymphoblastic leukaemia cells to oxidative stress. British Journal of Haematology. 148: 714-25. PMID 19912216 DOI: 10.1111/j.1365-2141.2009.07983.x  1
2010 Dibirdik I, Yiv S, Qazi S, Uckun FM. In vivo anti-cancer activity of a liposomal nanoparticle construct of multifunctional tyrosine kinase inhibitor 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline Journal of Nanomedicine and Nanotechnology. 1. DOI: 10.4172/2157-7439.1000101  1
2010 Uckun FM, Dibirdik I, Qazi S, Yiv S. Therapeutic nanoparticle constructs of a JAK3 tyrosine kinase inhibitor against human B-lineage ALL cells (Arzneimittelforschung (2010) 60, 4, (210-217)) Arzneimittel-Forschung/Drug Research. 60: 286.  1
2008 Uckun FM, Tibbles H, Ozer Z, Qazi S, Vassilev A. Anti-inflammatory activity profile of JANEX-1 in preclinical animal models. Bioorganic & Medicinal Chemistry. 16: 1287-98. PMID 18024136 DOI: 10.1016/j.bmc.2007.10.066  1
2007 Uckun FM, Erbeck D, Qazi S, Venkatachalam T, Tibbles HE, Vassilev A. Effect of targeting janus kinase 3 on the development of intestinal tumors in the adenomatous polyposis coli(min) mouse model of familial adenomatous polyposis. Arzneimittel-Forschung. 57: 320-9. PMID 17688077 DOI: 10.1055/s-0031-1296626  1
2007 Uckun FM, Qazi S, Venkatachalam T. N'-[2-(2-thiophene) ethyl]-N'-[2-(5-bromopyridyl)]thiourea (HI-443), a rationally designed non-nucleoside reverse transcriptase inhibitor compound with potent anti-HIV activity. Arzneimittel-Forschung. 57: 278-85. PMID 17598700 DOI: 10.1055/s-0031-1296619  1
2007 Uckun FM, Tibbles H, Erbeck D, Venkatachalam TK, Qazi S. In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443). Arzneimittel-Forschung. 57: 218-26. PMID 17515292 DOI: 10.1055/s-0031-1296608  1
2007 Qazi S, Caberlin M, Nigam N. Mechanism of psychoactive drug action in the brain: simulation modeling of GABAA receptor interactions at non-equilibrium conditions. Current Pharmaceutical Design. 13: 1437-55. PMID 17504166 DOI: 10.2174/138161207780765972  1
2007 Qazi S, DuMez D, Uckun FM. Meta analysis of advanced cancer survival data using lognormal parametric fitting: a statistical method to identify effective treatment protocols. Current Pharmaceutical Design. 13: 1533-44. PMID 17504149 DOI: 10.2174/138161207780765882  1
2007 Uckun FM, Erbeck D, Tibbles H, Qazi S, Venkatachalam TK. Improved oral bioavailability of anti-HIV agent N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443) in a novel lipophilic formulation. Arzneimittel-Forschung. 57: 164-70. PMID 17469651 DOI: 10.1055/s-0031-1296600  1
2007 Uckun FM, DuMez D, Qazi S, Tibbles H, Venkatachalam TK. Anti-retroviral activity of GMP-grade stampidine against genotypically and phenotypically nucleoside reverse transcriptase inhibitor resistant recombinant human immunodeficiency virus. An in vitro study. Arzneimittel-Forschung. 57: 112-21. PMID 17396622 DOI: 10.1055/s-0031-1296592  1
2007 Uckun FM, Dibirdik I, Qazi S, Vassilev A, Ma H, Mao C, Benyumov A, Emami KH. Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK). Bioorganic & Medicinal Chemistry. 15: 800-14. PMID 17098432 DOI: 10.1016/j.bmc.2006.10.050  1
2006 Uckun FM, Morar S, Qazi S. Vinorelbine-based salvage chemotherapy for therapy-refractory aggressive leukaemias. British Journal of Haematology. 135: 500-8. PMID 17061978 DOI: 10.1111/j.1365-2141.2006.06338.x  1
2006 Lundell K, Qazi S, Eddy L, Uckun FM. Clinical activity of folinic acid in patients with chronic fatigue syndrome. Arzneimittel-Forschung. 56: 399-404. PMID 16889122 DOI: 10.1055/s-0031-1296741  1
2006 Venkatachalam TK, Sarquis M, Qazi S, Uckun FM. Effect of alkyl groups on the cellular hydrolysis of stavudine phosphoramidates. Bioorganic & Medicinal Chemistry. 14: 6420-33. PMID 16782353 DOI: 10.1016/j.bmc.2006.05.037  1
2006 Venkatachalam TK, Qazi S, Uckun FM. Synthesis and metabolism of naphthyl substituted phosphoramidate derivatives of stavudine. Bioorganic & Medicinal Chemistry. 14: 5161-77. PMID 16697204 DOI: 10.1016/j.bmc.2006.04.006  1
2006 Uckun FM, Venkatachalam TK, Qazi S. Potency of stampidine against multi-nucleoside reverse transcriptase inhibitor resistant human immunodeficiency viruses. Arzneimittel-Forschung. 56: 193-203. PMID 16570827 DOI: 10.1055/s-0031-1296806  1
2006 Venkatachalam TK, Qazi S, Uckun FM. Site-specific enzymatic activation of the anti-HIV agent stampidine. Arzneimittel-Forschung. 56: 167-75. PMID 16570825 DOI: 10.1055/s-0031-1296804  1
2006 Venkatachalam TK, Qazi S, Uckun FM. Synthesis, separation and anti-HIV activity of distereoisomers of N-[p-(4-bromophenyl) -2',3'-didehydro-3'-deoxy-5'-thymidylyl]-L-alanine methyl ester (stampidine). Arzneimittel-Forschung. 56: 152-8. PMID 16570823 DOI: 10.1055/s-0031-1296802  1
2005 Venkatachalam TK, Samuel P, Qazi S, Uckun FM. Effect of change in nucleoside structure on the activation and antiviral activity of phosphoramidate derivatives. Bioorganic & Medicinal Chemistry. 13: 5408-23. PMID 15994083 DOI: 10.1016/j.bmc.2005.04.083  1
2005 Uckun FM, Qazi S, Venkatachalam TK. In vitro anti-HIV potency of stampidine alone and in combination with standard anti-HIV drugs. Arzneimittel-Forschung. 55: 223-31. PMID 15901046 DOI: 10.1055/s-0031-1296849  1
2005 Venkatachalam TK, Samuel P, Qazi S, Uckun FM. Protease-mediated enzymatic hydrolysis and activation of aryl phosphoramidate derivatives of stavudine. European Journal of Medicinal Chemistry. 40: 452-66. PMID 15893019 DOI: 10.1016/j.ejmech.2004.11.015  1
2004 Uckun FM, Vassilev AO, Dibirdik I, Liu XP, Erbeck D, Tibbles HE, Qazi S, Venkatachalam TK. Anti-cancer activity profile of 3'-azidothymidine 5'-[p-methoxyphenyl methoxyalaninyl phosphate] (Compound 003), a novel nucleoside analog. Arzneimittel-Forschung. 54: 715-31. PMID 15612613 DOI: 10.1055/s-0031-1297029  1
2004 Venkatachalam TK, Yu G, Samuel P, Qazi S, Pendergrass S, Uckun FM. A comparative study of the hydrolysis pathways of substituted aryl phosphoramidate versus aryl thiophosphoramidate derivatives of stavudine. European Journal of Medicinal Chemistry. 39: 665-83. PMID 15276300 DOI: 10.1016/j.ejmech.2004.04.002  1
2004 Venkatachalam TK, Goodman PA, Qazi S, D'Cruz O, Uckun FM. Rational drug design of multifunctional phosphoramidate substituted nucleoside analogs. Current Pharmaceutical Design. 10: 1713-26. PMID 15180534 DOI: 10.2174/1381612043384484  1
2004 Venkatachalam TK, Samuel P, Li G, Qazi S, Mao C, Pendergrass S, Uckun FM. Lipase-mediated stereoselective hydrolysis of stampidine and other phosphoramidate derivatives of stavudine. Bioorganic & Medicinal Chemistry. 12: 3371-81. PMID 15158806 DOI: 10.1016/j.bmc.2004.03.068  1
2004 Uckun FM, Pendergrass S, Qazi S, Samuel P, Venkatachalam TK. Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against adenovirus. European Journal of Medicinal Chemistry. 39: 225-34. PMID 15051170 DOI: 10.1016/j.ejmech.2003.12.002  1
2004 Uckun FM, Pendergrass S, Qazi S, Venkatachalam TK. In vitro activity of stampidine against primary clinical human immunodeficiency virus isolates. Arzneimittel-Forschung. 54: 69-77. PMID 14979612 DOI: 10.1055/s-0031-1296939  1
2004 Qazi S, Beltukov A, Trimmer BA. Simulation modeling of ligand receptor interactions at non-equilibrium conditions: processing of noisy inputs by ionotropic receptors. Mathematical Biosciences. 187: 93-110. PMID 14609637 DOI: 10.1016/j.mbs.2003.01.001  1
2003 Uckun FM, Chen CL, Samuel P, Pendergrass S, Venkatachalam TK, Waurzyniak B, Qazi S. In vivo antiretroviral activity of stampidine in chronically feline immunodeficiency virus-infected cats. Antimicrobial Agents and Chemotherapy. 47: 1233-40. PMID 12654652 DOI: 10.1128/AAC.47.4.1233-1240.2003  1
2003 Venkatachalam TK, Qazi S, Samuel P, Uckun FM. Substituted heterocyclic thiourea compounds as a new class of anti-allergic agents inhibiting IgE/Fc epsilon RI receptor mediated mast cell leukotriene release. Bioorganic & Medicinal Chemistry. 11: 1095-105. PMID 12614897 DOI: 10.1016/S0968-0896(02)00531-X  1
2003 Venkatachalam TK, Qazi S, Samuel P, Uckun FM. Inhibition of mast cell leukotriene release by thiourea derivatives. Bioorganic & Medicinal Chemistry Letters. 13: 485-8. PMID 12565956 DOI: 10.1016/S0960-894X(02)00992-7  1
2003 Qazi S, Samuel NK, Venkatachalam TK, Uckun FM. Evaluating dissolution profiles of an anti-HIV agent using ANOVA and non-linear regression models in JMP software. International Journal of Pharmaceutics. 252: 27-39. PMID 12550778 DOI: 10.1016/S0378-5173(02)00603-8  1
2002 Uckun FM, Samuel P, Qazi S, Chen C, Pendergrass S, Venkatachalam TK. Effects of aryl substituents on the anti-HIV activity of the arylphosphoramidate derivatives of stavudine. Antiviral Chemistry & Chemotherapy. 13: 197-203. PMID 12448692  1
2002 D'Cruz OJ, Venkatachalam TK, Mao C, Qazi S, Uckun FM. Structural requirements for potent anti-human immunodeficiency virus (HIV) and sperm-immobilizing activities of cyclohexenyl thiourea and urea non-nucleoside inhibitors of HIV-1 reverse transcriptase. Biology of Reproduction. 67: 1959-74. PMID 12444075 DOI: 10.1095/biolreprod.102.006478  1
2002 Zayas RM, Qazi S, Morton DB, Trimmer BA. Nicotinic-acetylcholine receptors are functionally coupled to the nitric oxide/cGMP-pathway in insect neurons. Journal of Neurochemistry. 83: 421-31. PMID 12423252 DOI: 10.1046/j.1471-4159.2002.01147.x  1
2002 Uckun FM, Pendergrass S, Venkatachalam TK, Qazi S, Richman D. Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations. Antimicrobial Agents and Chemotherapy. 46: 3613-6. PMID 12384373 DOI: 10.1128/AAC.46.11.3613-3616.2002  1
2002 Uckun FM, Qazi S, Pendergrass S, Lisowski E, Waurzyniak B, Chen CL, Venkatachalam TK. In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of stavudine-5'-(p-bromophenyl methoxyalaninyl phosphate) (stampidine) in mice. Antimicrobial Agents and Chemotherapy. 46: 3428-36. PMID 12384347 DOI: 10.1128/AAC.46.11.3428-3436.2002  1
2001 Vermehren A, Qazi S, Trimmer BA. The nicotinic alpha subunit MARA1 is necessary for cholinergic evoked calcium transients in Manduca neurons. Neuroscience Letters. 313: 113-6. PMID 11682140 DOI: 10.1016/S0304-3940(01)02228-5  1
2001 Trimmer BA, Aprille JR, Dudzinski DM, Lagace CJ, Lewis SM, Michel T, Qazi S, Zayas RM. Nitric oxide and the control of firefly flashing. Science (New York, N.Y.). 292: 2486-8. PMID 11431567 DOI: 10.1126/science.1059833  1
2001 Pfarr KM, Qazi S, Fuhrman JA. Nitric oxide synthase in filariae: demonstration of nitric oxide production by embryos in Brugia malayi and Acanthocheilonema viteae. Experimental Parasitology. 97: 205-14. PMID 11384164 DOI: 10.1006/expr.2001.4613  1
2000 Zayas RM, Qazi S, Morton DB, Trimmer BA. Neurons involved in nitric oxide-mediated cGMP signaling in the tobacco hornworm, Manduca sexta. The Journal of Comparative Neurology. 419: 422-38. PMID 10742713 DOI: 10.1002/(SICI)1096-9861(20000417)419:4<422::AID-CNE2>3.0.CO;2-S  1
1999 Qazi S, Trimmer BA. The role of nitric oxide in motoneuron spike activity and muscarinic-evoked changes in cGMP in the CNS of larval Manduca sexta. Journal of Comparative Physiology. a, Sensory, Neural, and Behavioral Physiology. 185: 539-50. PMID 10633555 DOI: 10.1007/s003590050414  1
1999 Qazi S, Trimmer BA. The role of inositol 1,4,5-trisphosphate 5-phosphatase in inositol signaling in the CNS of larval Manduca sexta. Insect Biochemistry and Molecular Biology. 29: 161-75. PMID 10196739 DOI: 10.1016/S0965-1748(98)00120-9  1
1996 Qazi S, Proulx D, Trimmer BA. Characterization of muscarinic binding sites in the central nervous system of larval Manduca sexta. Insect Biochemistry and Molecular Biology. 26: 721-32. PMID 8995794 DOI: 10.1016/S0965-1748(96)00042-2  1
1996 Trimmer BA, Qazi S. Modulation of second messengers in the nervous system of larval Manduca sexta by muscarinic receptors. Journal of Neurochemistry. 66: 1903-13. PMID 8780017  1
Show low-probability matches.